Literature DB >> 11731100

Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation.

I N Krasnova1, B Ladenheim, S Jayanthi, J Oyler, T H Moran, M A Huestis, J L Cadet.   

Abstract

In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in amphetamine-induced dopaminergic damage, the drug was injected to mice with different levels of copper/zinc superoxide dismutase (Cu/Zn SOD) enzyme. Administration of amphetamine (10 mg/kg, i.p., given every 2 h, a total of four times) to wild-type CD-1 and C57BL/6J mice caused significant decreases in dopamine and 3,4-dihydroxyphenylacetic acid levels, in [(125)I]RTI-121-labeled dopamine transporters as well as a significant depletion in the concentration of dopamine transporter and vesicular monoamine transporter 2 proteins. The amphetamine-induced toxic effects were less prominent in CD-1 mice, which have much higher levels of Cu/Zn SOD activity (0.69 units/mg of protein) in their striata than C57BL/6J animals (0.007 units/mg of protein). Transgenic mice on CD-1 and C57BL/6J background, which had striatal levels of Cu/Zn SOD 2.57 and 1.67 units/mg of protein, respectively, showed significant protection against all the toxic effects of amphetamine. The attenuation of toxicity observed in transgenic mice was not caused by differences in amphetamine accumulation in wild-type and mutant animals. However, CD-1-SOD transgenic mice showed marked hypothermia to amphetamine whereas C57-SOD transgenic mice did not show a consistent thermic response to the drug. The data obtained demonstrate distinctions in the neurotoxic profile of amphetamine in CD-1 and C57BL/6J mice, which show some differences in Cu/Zn SOD activity and in their thermic responses to amphetamine administration. Thus, these observations provide evidence for possible complex interactions between thermoregulation and free radical load in the long-term neurotoxic effects of this illicit drug of abuse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731100     DOI: 10.1016/s0306-4522(01)00351-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Dopaminergic system dysfunction in recreational dexamphetamine users.

Authors:  Anouk Schrantee; Lena Václavů; Dennis F R Heijtel; Matthan W A Caan; Willy Gsell; Paul J Lucassen; Aart J Nederveen; Jan Booij; Liesbeth Reneman
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

2.  Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assay.

Authors:  Abir T El-Alfy; Lisa Wilson; Mahmoud A ElSohly; Ehab A Abourashed
Journal:  J Ethnopharmacol       Date:  2009-08-22       Impact factor: 4.360

3.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

4.  Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.

Authors:  Charles V Vorhees; Elizabeth He; Matthew R Skelton; Devon L Graham; Tori L Schaefer; Curtis E Grace; Amanda A Braun; Robyn Amos-Kroohs; Michael T Williams
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

5.  Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii.

Authors:  Geetha Kannan; Joshua A Crawford; ChunXia Yang; Kristin L Gressitt; Chinezimuzo Ihenatu; Irina N Krasnova; Jean Lud Cadet; Robert H Yolken; Emily G Severance; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2016-03-08       Impact factor: 5.996

Review 6.  "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Oluwatosin O Fatusin; Qing-Rong Liu; Carlo Contoreggi; Chuan-Yun Li; Kari Buck; John Crabbe
Journal:  Biochem Pharmacol       Date:  2007-07-25       Impact factor: 5.858

7.  Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry.

Authors:  Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-02-21       Impact factor: 4.142

8.  Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.

Authors:  Karl B Scheidweiler; Bruce Ladenheim; Jean Lud Cadet; Marilyn A Huestis
Journal:  Neurotox Res       Date:  2009-10-23       Impact factor: 3.911

9.  Amphetamine causes dopamine depletion and cell death in the mouse olfactory bulb.

Authors:  Fidelis E Atianjoh; Bruce Ladenheim; Irina N Krasnova; Jean Lud Cadet
Journal:  Eur J Pharmacol       Date:  2008-05-15       Impact factor: 4.432

Review 10.  Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Authors:  Jean Lud Cadet; Irina N Krasnova; Subramaniam Jayanthi; Johnalyn Lyles
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.